Condition
Nausea and Vomiting clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Nausea and Vomiting clinical trials that are recruiting, at sites in 3 countries (most in China (3), United States (2), Lebanon (1)). By phase: Phase 3 (3), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 3Countries
Newest Nausea and Vomiting clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Sedation with dexmedetomidine, propofol, or both during cataract surgery | — | Beirut | Recruiting | Apr 29, 2026 |
| Tradipitant for GLP-1R agonist–related nausea and vomiting in adults with overweight or class I–II obesity | Phase 3 | Los Angeles, California and 9 other locations | Recruiting | Mar 3, 2026 |
| Using Fosaprepitant to Treat Nausea and Vomiting | Phase 2/3 | The Bronx, New York | Recruiting | Apr 24, 2024 |
| Combining electroacupuncture with antiemetic therapy for nausea in breast cancer patients | Phase 3 | Lanzhou, Gansu | Recruiting | Mar 18, 2024 |
| Using electroacupuncture to prevent nausea and vomiting in breast cancer patients undergoing chemotherapy | Phase 3 | Xining, Qinghai | Recruiting | Jan 10, 2024 |
| Evaluating Palonosetron Hydrochloride Capsules for Preventing Nausea and Vomiting from Chemotherapy | — | Xi'an, Shaan'xi | Recruiting | Jan 19, 2023 |
All recruiting trials (6)
-
Sedation with dexmedetomidine, propofol, or both during cataract surgery
This project will test whether dexmedetomidine, propofol, or their combination (each given with fentanyl) provides the best sedation, safety, and surgeon satisfaction for adults having cataract surgery.
-
Tradipitant for GLP-1R agonist–related nausea and vomiting in adults with overweight or class I–II obesity
This trial will test if tradipitant can reduce nausea and vomiting caused by GLP-1 receptor agonist weight-loss medicines in adults who are overweight or have class I–II obesity.
-
Using Fosaprepitant to Treat Nausea and Vomiting
This study is testing if a new medication called fosaprepitant can help people with nausea and vomiting feel better compared to the usual treatment they receive.
-
Combining electroacupuncture with antiemetic therapy for nausea in breast cancer patients
This study is testing if combining electroacupuncture with standard anti-nausea medication can help breast cancer patients feel less sick during chemotherapy.
-
Using electroacupuncture to prevent nausea and vomiting in breast cancer patients undergoing chemotherapy
This study is testing if adding electroacupuncture to regular anti-nausea medications can help breast cancer patients undergoing chemotherapy avoid nausea and vomiting.
-
Evaluating Palonosetron Hydrochloride Capsules for Preventing Nausea and Vomiting from Chemotherapy
This study tests if Palonosetron hydrochloride capsules can help cancer patients avoid nausea and vomiting from chemotherapy better than traditional IV treatments.
Related topics
Quick answers
How many Nausea and Vomiting clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (3 trials), United States (2 trials), Lebanon (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 3, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.